Bern (ots) - Nicht jeder Kindersitz passt in jedes Auto. Deshalb hat der TCS auch dieses Jahr wieder ...
Girindus AG - Oligonucleotide Production Expansion Accelerated
Bensberg (ots) - Girindus, with core competencies in process development, scale up and manufacture of innovative drug and cosmetic actives, sees a significant increase in demand for its commercial oligonucleotide production capabilities in the USA and Europe.
"Our know-how and our technical expertise in the area of oligonucleotide research, development and manufacturing has been validated by an increased market demand. To respond to this demand we have accelerated the expansion program of our US commercial cGMP manufacturing facility located in Cincinnati Ohio", commented the CEO Robert F. Link.
In addition to the solid phase production in Cincinnati Girindus offers a unique solution phase process at its European facility which is targeted towards the cost-efficient manufacture of large commercial quantities.
digital press kits: http://presseportal.de/story.htx?firmaid=23521
press kits via RSS: feed://presseportal.de/rss/pm_23521.rss2
ots Originaltext: Girindus AG
Peter J. Bergsteiner,
Director Investor Relations
Girindus AG, 51402 Bensberg